Inify Laboratories

Less than 1K followers

INIFY

Euronext Growth Oslo

Medical Equipment & Services

Health Care

Overview

Investor consensus

Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially in prostate diagnostics. Customers primarily consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and is headquartered in Stockholm, Sweden.

Market cap

-

Turnover

-

Revenue

13.5M

EBIT %

-403.58 %

P/E

-

Dividend yield-%

-

Financial calendar

25/2

2026

Annual report '25

29/4

2026

Interim report Q1'26

20/5

2026

General meeting '26

All

Press releases

ShowingAll content types

Regulatory press release1/30/2026, 8:30 AM

Correction: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release1/30/2026, 8:30 AM

Inify Laboratories AB: Correction: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release1/27/2026, 5:51 PM

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release1/27/2026, 5:51 PM

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release1/27/2026, 5:46 PM

Inify Laboratories - Final Results of the Repair Issue

Inify Laboratories

Regulatory press release1/27/2026, 5:46 PM

Inify Laboratories AB: Inify Laboratories - Final Results of the Repair Issue

Inify Laboratories

Regulatory press release1/12/2026, 7:00 AM

Inify Laboratories - Commencement of subscription period for Repair Issue

Inify Laboratories

Regulatory press release1/12/2026, 7:00 AM

Inify Laboratories AB: Inify Laboratories - Commencement of subscription period for Repair Issue

Inify Laboratories

Regulatory press release12/19/2025, 12:25 PM

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release12/19/2025, 12:24 PM

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release12/19/2025, 12:18 PM

INIFY: Inify Laboratories announces final results of fully guaranteed private placement

Inify Laboratories

Regulatory press release12/19/2025, 12:18 PM

Inify Laboratories AB: Inify Laboratories announces final results of fully guaranteed private placement

Inify Laboratories

Regulatory press release12/19/2025, 7:36 AM

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release12/17/2025, 7:15 AM

Inify Laboratories: Key information regarding Repair Issue

Inify Laboratories

Regulatory press release12/17/2025, 7:15 AM

Inify Laboratories AB: Inify Laboratories: Key information regarding Repair Issue

Inify Laboratories

Regulatory press release12/17/2025, 7:00 AM

INIFY: Inify Laboratories announces preliminary results of fully guaranteed private placement

Inify Laboratories

Regulatory press release12/17/2025, 7:00 AM

Inify Laboratories AB: Inify Laboratories announces preliminary results of fully guaranteed private placement

Inify Laboratories

Regulatory press release12/16/2025, 1:11 PM

Inify Laboratories - notification of trade

Inify Laboratories

Regulatory press release12/16/2025, 1:11 PM

Inify Laboratories AB: Inify Laboratories - notification of trade

Inify Laboratories

Regulatory press release12/9/2025, 7:00 AM

INIFY: Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue

Inify Laboratories

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.